Bone and joint disease in sickle cell disease

Area of Science:

• Orthopedics
• Hematology
• Rheumatology

Background:

• Sickle cell disease (SCD) is a genetic blood disorder characterized by abnormal hemoglobin.
• Bone and joint complications are prevalent in SCD, leading to significant morbidity and chronic pain.

Purpose of the Study:

• To review the multifaceted effects of sickle cell disease on bone and joint health.
• To discuss the common sites of bone destruction and complications in SCD patients.
• To highlight current and potential treatment options for these musculoskeletal issues.

Main Methods:

• Literature review of studies focusing on sickle cell disease and its orthopedic manifestations.
• Analysis of clinical data regarding common bone and joint complications.
• Synthesis of information on disease mechanisms and treatment efficacy.

Main Results:

• The femoral head is the most frequent site of bone destruction in sickle cell disease.
• Other common complications include avascular necrosis, spinal changes, infections, and bone marrow disturbances.
• Complications can affect epiphyseal, metaphyseal, and diaphyseal bone regions, with location and extent influencing pain and damage.

Conclusions:

• Sickle cell disease poses a significant threat to bone and joint integrity, with the hip joint being particularly vulnerable.
• Understanding the specific mechanisms and locations of bone and joint damage is crucial for effective management.
• Comprehensive treatment strategies are necessary to address the chronic pain and structural damage associated with these complications.